Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Westgren

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2019
Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host DiseaseBehnam Sadeghi, Mats Remberger, Britt Gustafsson, et al.
Stem Cells Translational Medicine|March 14, 2018
Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host DiseaseOlle Ringden, Arjang Baygan, Mats Remberger, et al.
The Journal of Clinical Investigation|August 16, 2013
Differentiation and functional regulation of human fetal NK cellsMartin A Ivarsson, Liyen Loh, Nicole Marquardt, et al.
Prenatal Diagnosis|October 31, 2025
Clinical Trials of Fetal Therapy With Continuing Neonatal Interventions: Legal Requirements and Customary Procedures Regarding Parental Consent. The BOOSTB4 Trial as a Case StudyEsther J Oldekamp, Martine C de Vries, Anna L David, et al.
Acta Paediatrica (Oslo, Norway : 1992)|September 24, 2013
EXPRESS study shows significant regional differences in 1-year outcome of extremely preterm infants in SwedenFredrik Serenius, Gunnar Sjörs, Mats Blennow, et al.
BMJ Open|January 1, 2018
Wait a minute? An observational cohort study comparing iron stores in healthy Swedish infants at 4 months of age after 10-, 60- and 180-second umbilical cord clampingUlrica Askelöf, Ola Andersson, Magnus Domellöf, et al.
European Journal of Human Genetics : EJHG|March 29, 2019
Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis ImperfectaMelissa Hill, Celine Lewis, Megan Riddington, et al.
Fetal Diagnosis and Therapy|April 22, 2015
Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized TrialNoortje P Paridaans, Marije M Kamphuis, Agneta Taune Wikman, et al.
European Journal of Human Genetics : EJHG|June 30, 2026
Parent and professional experiences of a clinical trial of prenatal and postnatal stem cell therapy for severe osteogenesis imperfectaBikiran Behera, Charlotta Ingvoldstad Malmgren, Eva Åström, et al.
European Journal of Immunology|December 16, 2024
Distinct Tissue-Dependent Composition and Gene Expression of Human Fetal Innate Lymphoid CellsInga E Rødahl, Martin A Ivarsson, Liyen Loh, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2019
Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host DiseaseBehnam Sadeghi, Mats Remberger, Britt Gustafsson, et al.
Stem Cells Translational Medicine|March 14, 2018
Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host DiseaseOlle Ringden, Arjang Baygan, Mats Remberger, et al.
The Journal of Clinical Investigation|August 16, 2013
Differentiation and functional regulation of human fetal NK cellsMartin A Ivarsson, Liyen Loh, Nicole Marquardt, et al.
Prenatal Diagnosis|October 31, 2025
Clinical Trials of Fetal Therapy With Continuing Neonatal Interventions: Legal Requirements and Customary Procedures Regarding Parental Consent. The BOOSTB4 Trial as a Case StudyEsther J Oldekamp, Martine C de Vries, Anna L David, et al.
Acta Paediatrica (Oslo, Norway : 1992)|September 24, 2013
EXPRESS study shows significant regional differences in 1-year outcome of extremely preterm infants in SwedenFredrik Serenius, Gunnar Sjörs, Mats Blennow, et al.
BMJ Open|January 1, 2018
Wait a minute? An observational cohort study comparing iron stores in healthy Swedish infants at 4 months of age after 10-, 60- and 180-second umbilical cord clampingUlrica Askelöf, Ola Andersson, Magnus Domellöf, et al.
European Journal of Human Genetics : EJHG|March 29, 2019
Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis ImperfectaMelissa Hill, Celine Lewis, Megan Riddington, et al.
Fetal Diagnosis and Therapy|April 22, 2015
Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized TrialNoortje P Paridaans, Marije M Kamphuis, Agneta Taune Wikman, et al.
European Journal of Human Genetics : EJHG|June 30, 2026
Parent and professional experiences of a clinical trial of prenatal and postnatal stem cell therapy for severe osteogenesis imperfectaBikiran Behera, Charlotta Ingvoldstad Malmgren, Eva Åström, et al.
European Journal of Immunology|December 16, 2024
Distinct Tissue-Dependent Composition and Gene Expression of Human Fetal Innate Lymphoid CellsInga E Rødahl, Martin A Ivarsson, Liyen Loh, et al.
Pageof 14